Delivra Health Brands (DHBUF) News

Latest news and analysis

Delivra Health Brands Surges 10.5% on Low Volume Trading

DHBUF climbs to $0.14 with modest trading activity as the micro-cap CBD company shows renewed investor interest despite limited financial data.

15h agoCannabismarketcap

Delivra Health Brands Surges 10.5% on Thin Volume Trading

DHBUF climbed to $0.14 with minimal trading activity, highlighting volatility risks in micro-cap CBD stocks amid limited financial transparency.

3d agoCannabismarketcap

Delivra Health Brands Surges 10.5% on Trading Volume Spike

DHBUF climbed to $0.14 amid increased investor interest, though remains well below 52-week highs.

4d agoCannabismarketcap

Delivra Health Brands Surges 10.5% as CBD Stock Shows Momentum

DHBUF jumped to $0.14 on modest volume, marking a significant gain for the micro-cap CBD company amid broader sector volatility.

6d agoCannabismarketcap

Delivra Health Brands Surges 10.5% on CBD Market Optimism

DHBUF climbs to $0.14 amid renewed investor interest in CBD sector, though trading remains light at 2,150 shares.

May 11, 2026Cannabismarketcap

Delivra Health Brands Surges 10.5% as CBD Stock Gains Momentum

DHBUF climbed to $0.14 on modest volume, marking significant recovery from 52-week lows in volatile OTC cannabis market.

May 8, 2026Cannabismarketcap

Delivra Health Brands Surges 10.5% on Light Volume Trading

DHBUF climbed to $0.14 amid renewed interest in CBD sector, though low trading volume raises questions about sustainability of the move.

May 7, 2026Cannabismarketcap

Delivra Health Brands Surges 10.5% on Light Volume

DHBUF climbed to $0.14 amid modest trading activity, marking a notable recovery from its 52-week lows despite limited financial disclosure.

May 5, 2026Cannabismarketcap

Delivra Health Brands Surges 10.5% as CBD Sector Shows Signs of Life

DHBUF climbs to $0.14 amid renewed interest in penny stock CBD plays, though limited volume raises questions about sustainability.

May 4, 2026Cannabismarketcap

Delivra Health Brands Secures Peak Processing Deal for LivRelief Growth

DHBUF partners with Peak Processing Solutions to expand manufacturing capacity for its topical pain relief products, targeting increased market penetration.

May 2, 2026Cannabismarketcap

Frequently Asked Questions

Where can I find reliable news about Delivra Health Brands (DHBUF)?+
Cannabismarketcap aggregates news from over 20 trusted cannabis industry sources including Marijuana Moment, MJBizDaily, New Cannabis Ventures, and major financial outlets. For DHBUF specifically, you can follow this page for curated news, check the company's SEC filings for official announcements, and monitor press releases on their investor relations page. Industry-specific sources tend to provide more detailed cannabis coverage than general financial media.
How does news affect DHBUF's stock price?+
News can significantly impact Delivra Health Brands's stock price, especially in the cannabis sector where stocks tend to be more volatile. Regulatory news (federal legalization updates, state license approvals, DEA rescheduling) typically has the biggest impact across the entire sector. Company-specific news like earnings reports, acquisition announcements, executive changes, and new market entries directly affect DHBUF. Cannabis stocks can move 5-20% on significant news due to lower liquidity and high retail investor participation.
What news sources cover the cannabis industry?+
Major cannabis-specific news outlets include Marijuana Moment (policy and politics), MJBizDaily (business and industry), New Cannabis Ventures (public company focus), Leafly (consumer and science), High Times (culture and business), and Cannabis Wire (investigative journalism). Financial coverage comes from Benzinga Cannabis, Motley Fool, Yahoo Finance, and Seeking Alpha. International sources include Prohibition Partners, StratCann (Canada), and Mugglehead. Each source has different strengths and editorial perspectives.
How should I evaluate cannabis news for investing in DHBUF?+
When reading cannabis news, consider the source's credibility, whether claims are backed by official filings or named sources, and the potential timeline for any regulatory changes. Distinguish between confirmed developments (SEC filings, signed legislation) and speculation (rumored M&A, proposed bills). For Delivra Health Brands, focus on news that directly affects its operations: state market developments where it operates, regulatory changes affecting its license type, and competitive dynamics in its key markets.
What types of news have the most impact on cannabis stocks like DHBUF?+
The most impactful news categories for cannabis stocks are: (1) Federal regulatory changes like rescheduling, SAFE Banking, or legalization bills, which can move the entire sector 10-30%; (2) Earnings reports and guidance updates; (3) M&A announcements; (4) State-level regulatory decisions (new licenses, market openings); (5) FDA or Health Canada decisions on specific products; and (6) Major institutional investor activity. For DHBUF specifically, news about its operating markets and competitive position tends to have the most direct impact.
How often is DHBUF news updated on Cannabismarketcap?+
Cannabismarketcap updates cannabis news continuously throughout the day, with new articles published as developments occur. Our news feed aggregates from 20+ sources and covers both company-specific news and broader industry developments. For Delivra Health Brands, articles are automatically tagged when they mention DHBUF, so this page always shows the most recent coverage. Check back regularly or visit our main news page for comprehensive industry coverage.

More on DHBUF